High materiality8/10
ProMIS Neurosciences price target raised to $33 from $20 at Chardan
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
very_bullish
What happened, with direct paths to the underlying reporting
Chardan raises PMN target to $33; current price $16.07.
Target: $33
Posted price: $16.07
Analyst firm: Chardan Capital
Analyst: Keay Nakae
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.